Tenax Therapeutics Inc

Research Tenax Therapeutics Inc (TENX) on Bullrun: market cap USD 358.09M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerTENX
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 358.09M
• Financial periodFY2025
• Net income-USD 52.60M

Valuation Snapshot

latest market cap is USD 358.09M.

About Tenax Therapeutics Inc

Tenax Therapeutics, Inc., a development-stage pharmaceutical company, develops novel cardiopulmonary therapies in the United States. It develops TNX-101, TNX-102, and TNX-103 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension in heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia.

Frequently asked questions

What is Tenax Therapeutics Inc's market cap?

Tenax Therapeutics Inc's market capitalization is USD 358.09M.

What does Tenax Therapeutics Inc do?

Tenax Therapeutics, Inc., a development-stage pharmaceutical company, develops novel cardiopulmonary therapies in the United States.